FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Enrico Veltri

Research Profile

Chemicals & Drugs

Disorders

Hypercholesterolemia

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
David A Morrow; Benjamin M Scirica; Keith A A Fox; Gail Berman; John Strony; Enrico Veltri; Marc P Bonaca; Polly Fish; Carolyn H McCabe; Eugene Braunwald
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
Robert P Giugliano; Jennifer A White; Christoph Bode; Paul W Armstrong; Gilles Montalescot; Basil S. Lewis; Arnoud van 't Hof; Lisa G Berdan; Kerry L Lee; John Strony; Steven Hildemann; Enrico Veltri; Frans Van de Werf; Eugene Braunwald; Robert A Harrington; Robert M Califf; L Kristin Newby
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
Richard C Becker; David J Moliterno; Lisa K Jennings; Karen S Pieper; Jinglan Pei; Alan Niederman; Khaled M Ziada; Gail Berman; John Strony; Diane Joseph; Kenneth W Mahaffey; Frans Van de Werf; Enrico Veltri; Robert A Harrington
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Enrico Veltri (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: David A Morrow; Benjamin M Scirica; Keith A A Fox; Gail Berman; John Strony; Enrico Veltri; Marc P Bonaca; Polly Fish; Carolyn H McCabe; Eugene Braunwald
Evaluation of a novel antiplatelet agent for secondary prevention in patients with a history of atherosclerotic disease: design and rationale for the Thrombin-Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2 degrees P)-TIMI 50 trial.
American heart journal 2009;158(3):335-341.e3.
2009: Robert P Giugliano; Jennifer A White; Christoph Bode; Paul W Armstrong; Gilles Montalescot; Basil S. Lewis; Arnoud van 't Hof; Lisa G Berdan; Kerry L Lee; John Strony; Steven Hildemann; Enrico Veltri; Frans Van de Werf; Eugene Braunwald; Robert A Harrington; Robert M Califf; L Kristin Newby
Early versus delayed, provisional eptifibatide in acute coronary syndromes.
The New England journal of medicine 2009;360(21):2176-90.
2009: Richard C Becker; David J Moliterno; Lisa K Jennings; Karen S Pieper; Jinglan Pei; Alan Niederman; Khaled M Ziada; Gail Berman; John Strony; Diane Joseph; Kenneth W Mahaffey; Frans Van de Werf; Enrico Veltri; Robert A Harrington
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
Lancet 2009;373(9667):919-28.
2009: Thomas A Pearson; Christie M Ballantyne; Enrico Veltri; Arvind Shah; Steven Bird; Jianxin Lin; Elizabeth Rosenberg; Andrew M Tershakovec
Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy.
The American journal of cardiology 2009;103(3):369-74.
2008: John Strony; Robert J Hoffman; Mary Hanson; Enrico Veltri
Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.
Clinical therapeutics 2008;30(12):2280-97.
2008: John Strony; Bo Yang; Mary E Hanson; Enrico Veltri
Long-term safety and tolerability of ezetimibe coadministered with simvastatin in hypercholesterolemic patients: a randomized, 12-month double-blind extension study.
Current medical research and opinion 2008;24(11):3149-57.
2008: Anouk van der Graaf; Cynthia Cuffie-Jackson; Maud N Vissers; Mieke D Trip; Claude Gagné; Genming Shi; Enrico Veltri; Hans J Avis; John J P Kastelein
Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
Journal of the American College of Cardiology 2008;52(17):1421-9.
2008: John J P Kastelein; Fatima Akdim; Erik S G Stroes; Aeilko H Zwinderman; Michiel Bots; Anton F H Stalenhoef; Frank L J Visseren; Eric J G Sijbrands; Mieke D Trip; Evan A Stein; Daniel Gaudet; Raphael Duivenvoorden; Enrico Veltri; Adrian David Marais; Eric de Groot
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
The New England journal of medicine 2008;358(14):1431-43.
2007: Thomas A Pearson; Christie M Ballantyne; Christine Sisk; Arvind Shah; Enrico Veltri; Darbie Maccubbin
Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.
The American journal of cardiology 2007;99(12):1706-1713.
2007: Harry R Davis; Enrico Veltri
Zetia: inhibition of Niemann-Pick C1 Like 1 (NPC1L1) to reduce intestinal cholesterol absorption and treat hyperlipidemia.
Journal of atherosclerosis and thrombosis 2007;14(3):99-108.
2007: Theodore Feldman; Leiv Ose; Arvind Shah; Michelle Zakson; Alan Meehan; Amy O Johnson-Levonas; Darbie Maccubbin; Diane L Tribble; Enrico Veltri; Yale B Mitchel
Efficacy and safety of ezetimibe/simvastatin versus simvastatin monotherapy in hypercholesterolemic patients with metabolic syndrome.
Metabolic syndrome and related disorders 2007;5(1):13-21.
2006: Theodore Feldman; Michael Davidson; Arvind Shah; Darbie Maccubbin; Alan Meehan; Michelle Zakson; Diane L Tribble; Enrico Veltri; Yale B Mitchel
Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
Clinical therapeutics 2006;28(6):849-59.
2006: Roxanne A Rodney; Daniel Sugimoto; Bernard Wagman; Franklin Zieve; BORIS KERZNER; John Strony; Bo Yang; Ramachandran Suresh; Enrico Veltri
Efficacy and safety of coadministration of ezetimibe and simvastatin in African-American patients with primary hypercholesterolemia.
Journal of the National Medical Association 2006;98(5):772-8.
2006: Leiv Ose; Arvind Shah; Michael J Davies; Jennifer Rotonda; Darbie Maccubbin; Diane L Tribble; Enrico Veltri; Yale B Mitchel
Consistency of lipid-altering effects of ezetimibe/simvastatin across gender, race, age, baseline low density lipoprotein cholesterol levels, and coronary heart disease status: results of a pooled retrospective analysis.
Current medical research and opinion 2006;22(5):823-35.
2005: Glenn M Davies; John R Cook; John Erbey; Evo Alemao; Enrico Veltri
Projected coronary heart disease risk benefit with ezetimibe.
Atherosclerosis 2005;179(2):375-8.
2005: Philip T Sager; Rachel Capece; Leslie Lipka; John Strony; Bo Yang; Ramachandran Suresh; Yale B Mitchel; Enrico Veltri
Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients.
Atherosclerosis 2005;179(2):361-7.
2005: John J P Kastelein; Philip T Sager; Eric de Groot; Enrico Veltri
Comparison of ezetimibe plus simvastatin versus simvastatin monotherapy on atherosclerosis progression in familial hypercholesterolemia. Design and rationale of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) trial.
American heart journal 2005;149(2):234-9.
2004: Susan Bennett; Philip T Sager; Leslie Lipka; Lorenzo Melani; Ramachandran Suresh; Enrico Veltri
Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.
Journal of women's health (2002) 2004;13(10):1101-7.
2004: Evan Stein; Steen Stender; Pedro Mata; Philip T Sager; Damien Ponsonnet; Lorenzo Melani; Leslie Lipka; Ramachandran Suresh; Darbie Maccubbin; Enrico Veltri
Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
American heart journal 2004;148(3):447-55.
2004: Michael H Davidson; Christie M Ballantyne; BORIS KERZNER; Lorenzo Melani; Philip T Sager; Leslie Lipka; John Strony; Ramachandran Suresh; Enrico Veltri
Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia.
International journal of clinical practice 2004;58(8):746-55.
2004: Teddy Kosoglou; Paul Statkevich; Jean-Charles Fruchart; Laura J C Pember; Larisa Reyderman; David L Cutler; Michel Guillaume; Stephen E Maxwell; Enrico Veltri
Pharmacodynamic and pharmacokinetic interaction between fenofibrate and ezetimibe.
Current medical research and opinion 2004;20(8):1197-207.
2004: Christie M Ballantyne; Leslie Lipka; Philip T Sager; John Strony; J Alizadeh; Ramachandran Suresh; Enrico Veltri
Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia.
International journal of clinical practice 2004;58(7):653-8.
2004: Teddy Kosoglou; Paul Statkevich; Ingo Meyer; David L Cutler; Bernhard Musiol; Bo Yang; Yali Zhu; Stephen E Maxwell; Enrico Veltri
Effects of ezetimibe on the pharmacodynamics and pharmacokinetics of lovastatin.
Current medical research and opinion 2004;20(6):955-65.
2004: John R Cook; Don Yin; Evo Alemao; Glenn Davies; Karl J Krobot; Enrico Veltri; Leslie Lipka; Xavier Badia
Cost-effectiveness of ezetimibe coadministration in statin-treated patients not at cholesterol goal: application to Germany, Spain and Norway.
PharmacoEconomics 2004;22 Suppl 3():49-61.
2004: Leslie Lipka; Philip T Sager; John Strony; Bo Yang; Ramachandran Suresh; Enrico Veltri
Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia.
Drugs & aging 2004;21(15):1025-32.
2003: Philip T Sager; Lorenzo Melani; Leslie Lipka; John Strony; Bo Yang; Ramachandran Suresh; Enrico Veltri
Effect of coadministration of ezetimibe and simvastatin on high-sensitivity C-reactive protein.
The American journal of cardiology 2003;92(12):1414-8.
2003: Robert H Knopp; Carlos A Dujovne; A Le Beaut; Leslie Lipka; Ramachandran Suresh; Enrico Veltri
Evaluation of the efficacy, safety, and tolerability of ezetimibe in primary hypercholesterolaemia: a pooled analysis from two controlled phase III clinical studies.
International journal of clinical practice 2003;57(5):363-8.
2003: Christie M Ballantyne; John Houri; Alberto Notarbartolo; Lorenzo Melani; Leslie Lipka; Ramachandran Suresh; Steven Sun; LeBeaut Pierre Alexandre; Philip T Sager; Enrico Veltri
Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
Circulation 2003;107(19):2409-15.
2003: Robert H Knopp; H Gitter; T Truitt; Harold E Bays; C V Manion; Leslie Lipka; LeBeaut Pierre Alexandre; Ramachandran Suresh; Bo Yang; Enrico Veltri
Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemia.
European heart journal 2003;24(8):729-41.
2003: Lorenzo Melani; Richard Mills; David Hassman; Robert Lipetz; Leslie Lipka; LeBeaut Pierre Alexandre; Ramachandran Suresh; Pabak Mukhopadhyay; Enrico Veltri
Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial.
European heart journal 2003;24(8):717-28.
2003: Philip T Sager; Enrico Veltri
Ventricular tachycardia following ingestion of a commonly used antihistamine.
The Medical journal of Australia 2003;178(5):245-6; author reply 246.
2003: BORIS KERZNER; John Corbelli; Stephan Sharp; Leslie Lipka; Lorenzo Melani; LeBeaut Pierre Alexandre; Ramachandran Suresh; Pabak Mukhopadhyay; Enrico Veltri
Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemia.
The American journal of cardiology 2003;91(4):418-24.
2002: Michael H Davidson; Thomas McGarry; Robert Bettis; Lorenzo Melani; Leslie Lipka; LeBeaut Pierre Alexandre; Ramachandran Suresh; Steven Sun; Enrico Veltri
Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia.
Journal of the American College of Cardiology 2002;40(12):2125-34.
2002: Carlos A Dujovne; Mark P Ettinger; J Frederick McNeer; Leslie Lipka; LeBeaut Pierre Alexandre; Ramachandran Suresh; Bo Yang; Enrico Veltri
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia.
The American journal of cardiology 2002;90(10):1092-7.
2002: Teddy Kosoglou; Ingo Meyer; Enrico Veltri; Paul Statkevich; Bo Yang; Yali Zhu; Lillian Mellars; Stephen E Maxwell; James E Patrick; David L Cutler; Vijay K Batra; Melton Affrime
Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin.
British journal of clinical pharmacology 2002;54(3):309-19.
2001: Farkad Ezzet; David Wexler; Paul Statkevich; Teddy Kosoglou; J Patrick; Leslie Lipka; Lillian Mellars; Enrico Veltri; Vijay K Batra
The plasma concentration and LDL-C relationship in patients receiving ezetimibe.
Journal of clinical pharmacology 2001;41(9):943-9.
2001: Harold E Bays; P B Moore; M A Drehobl; S Rosenblatt; P D Toth; Carlos A Dujovne; Robert H Knopp; Leslie Lipka; LeBeaut Pierre Alexandre; Bo Yang; Lillian Mellars; C Cuffie-Jackson; Enrico Veltri
Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies.
Clinical therapeutics 2001;23(8):1209-30.
1998: Craig M Pratt; A John Camm; W Cooper; P L Friedman; D J MacNeil; K M Moulton; Bertram Pitt; Peter J Schwartz; Enrico Veltri; AL Waldo
Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die?
The American journal of cardiology 1998;81(7):869-76.